IO Biotech Inc
IOBT
Company Profile
Business description
IO Biotech Inc is a clinical-stage biopharmaceutical company developing novel, immune-modulating cancer vaccines based on T-win technology platform. The product candidates are designed to induce the immune system to simultaneously target and disrupt multiple pathways that regulate tumor-induced immunosuppression.
Contact
Ole Maaloes Vej 3
Copenhagen NDK-2200
DNKT: +45 70702980
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
31 December 2025
Employees
78
Stocks News & Analysis
stocks
Oracle shares are up 87% in 2025. Is it a buy?
Oracle’s cloud database business is riding the AI wave.
stocks
Is there a long-term buying opportunity in luxury stocks?
Our analysts think the recent wobble in revenue growth is cyclical, not structural.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,141.60 | 18.70 | 0.20% |
| CAC 40 | 7,830.11 | 23.48 | -0.30% |
| DAX 40 | 23,527.05 | 112.36 | -0.48% |
| Dow JONES (US) | 46,381.54 | 66.27 | 0.14% |
| FTSE 100 | 9,226.68 | 10.01 | 0.11% |
| HKSE | 26,080.30 | 263.84 | -1.00% |
| NASDAQ | 22,788.98 | 157.50 | 0.70% |
| Nikkei 225 | 45,493.66 | 447.85 | 0.99% |
| NZX 50 Index | 13,136.54 | 5.00 | -0.04% |
| S&P 500 | 6,693.75 | 29.39 | 0.44% |
| S&P/ASX 200 | 8,850.60 | 19.00 | 0.22% |
| SSE Composite Index | 3,788.05 | 40.53 | -1.06% |